Daniel S. Lorrain - 24 May 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTNM	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	24 May 2024	Class A Common Stock	100,000	$15.76	Direct	F1
transaction	CTNM	Stock Option (right to buy)	Award	$0	+3,700		$0.000000	3,700	24 May 2024	Class A Common Stock	3,700	$15.76	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"). 25% of the option shares vest on April 5, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.
F2	Options granted under the Plan. 25% of the option shares vest on April 5, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's spouse's continuous service.